JAMA Internal Medicine has reported that recommendations and clinical practice guidelines (CPGs) from the American College of Rheumatology (ACR) are often based on expert opinion, but lack rigorous (grade A) evidence to support many of their recommendations.
Patients and physicians are riddled with misconceptions when pregnancy is concerned.
Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com. This week he covers FDA warnings on gout drugs, steroid use in Australia, biosimilars lost savings and methotrexate hepatotoxicity in psoriatic arthritis (PsA).
Another year and another great ACR meeting. San Diego proved to be a an amazing host with the perfect combination of a convenient convention center with great lodging at walking distances from the conference, amazing food and superb weather.
Check out this compilation of our ACR17 Day 4 broadcasts, merged into a single one hour podcast !
This special edition of the RheumNow Week in Review covers highlights of selected sessions from the 2017 ACR annual meeting in San Diego. Dr.
While the incidence of pneumocystis pneumonia (PJP) is low is patients with rheumatologic diseases the mortality is quite high compared to PJP in patients with HIV and infection can be prevented with appropriate prophylaxis.
Clinical trials remain a challenge in SLE and a number of outcome measures have been used with varying success.
Two abstracts in this session sought to address novel ways to assess responses in SLE trials.
The pathogenesis between microscopic gut inflammation leading to the development of Crohn’s disease and sacroiliitis has been poorly understood. Dr. Debusschere, et al sought to understand this important link between IBD and axial SpA.
Janet Pope @Janetbirdope ( View Tweet )
Janet Pope @Janetbirdope ( View Tweet )
k dao @KDAO2011 ( View Tweet )
Janet Pope @Janetbirdope ( View Tweet )
Janet Pope @Janetbirdope ( View Tweet )
Links:
Dr. John Cush @RheumNow ( View Tweet )
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
